title: [Evaluation of the effects on the composition of alveolar surfactant of 2 chemotherapeutic protocols for carcinoma of the lung: peptichemio and MACC].
authors.forename: B
authors.initials: B
authors.lastname: Balbi
authors.forename: U
authors.initials: U
authors.lastname: Benatti
authors.forename: A
authors.initials: A
authors.lastname: Morelli
authors.forename: O
authors.initials: O
authors.lastname: Sacco
authors.forename: F
authors.initials: F
authors.lastname: Vassallo
authors.forename: G A
authors.initials: GA
authors.lastname: Rossi
authors.forename: C
authors.initials: C
authors.lastname: Ravazzoni
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D004317:Doxorubicin / Q000494:pharmacology / Q000627:therapeutic use; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D006801:Humans; D008130:Lomustine / Q000494:pharmacology / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008558:Melphalan / Q000031:analogs & derivatives*; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D010440:Peptichemio / Q000494:pharmacology* / Q000627:therapeutic use; D010743:Phospholipids / Q000032:analysis; D011663:Pulmonary Surfactants / Q000032:analysis / Q000187:drug effects*
chemical_list: D005227:Fatty Acids; D010743:Phospholipids; D011663:Pulmonary Surfactants; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D010440:Peptichemio; D008558:Melphalan; D008727:Methotrexate
vernacular_title: Valutazione degli effetti sulla composizione del surfattante alveolare di due protocolli chemioterapici per il carcinoma polmonare: peptichemio e MACC.